Man

Rodrigo Alejandro Santibáñez Moreira

Behavioral Neurologist

Pontificia Universidad Católica de Chile

Santiago, Chile

Líneas de Investigación


Behavioral Neurology, Cognitive Neurology, Dementia, Neurodegeneration, Alzheimer's Disease, Frontotemporal dementias, Autoimmune encephalitis

Educación

  •  Neurology, UNIVERSITY OF BRITISH COLUMBIA. Canada, 2017
  •  Neurology, PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Chile, 2015
  •  Doctor of Medicine, UNIVERSIDAD AUSTRAL DE CHILE. Chile, 2006
  •  Medicine, PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Chile, 2006

Experiencia Académica

  •   Instructor Full Time

    PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

    Medicine

    Santiago, Chile

    2015 - A la fecha

Experiencia Profesional

  •   Behavioral Neurologist Part Time

    Complejo Asistencial Doctor Sótero del Río

    Santiago, Chile

    2017 - 2024

  •   Behavioral Neurologist Full Time

    Red de Salud UC-Christus

    Santiago, Chile

    2017 - A la fecha

  •   Neurologist Part Time

    Complejo Asistencial Doctor Sótero del Río

    Santiago, Chile

    2015 - 2017

  •   Primary Care Physician Full Time

    Servicio de Salud Osorno

    Osorno, Chile

    2007 - 2015

  •   Instructor adjunto de neurología Full Time

    Pontificia Universidad Católica de Chile

    Santiago, Chile

    2018 - A la fecha


 

Article (4)

Phonological and Semantic Fluency in Alzheimer's Disease: A Systematic Review and Meta-Analysis
Allostatic-Interoceptive Overload in Frontotemporal Dementia
LGI1-antibody associated epilepsy successfully treated in the outpatient setting
The impact of SARS-CoV-2 in dementia across Latin America: A call for an urgent regional plan and coordinated response

BookSection (3)

A Woman with Progressive Episodic Memory Loss and Personality Change
Diagnóstico diferencial de otras demencias
Semiología de las demencias

Letter (1)

COVID-19 in older people with cognitive impairment in Latin America

Proyecto (10)

221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease (ENGAGE)
Mind Care Lab=> A Digital Tool for Early Detection of Cognitive Impairment
Transcranial Magnetic Stimulation in Nonfluent/Agrammatic Variant Primary Progressive Aphasia
A Medium Chain Triglyceride Intervention for Patients With Alzheimer Disease (MINT-01)
Comprehensive Assessment of Neurodegeneration and Dementia (COMPASS-ND)
CREAD Study=> A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)
Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)
An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease (AMARANTH)
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss (A4 Study)
Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects (LEFFTDS)
8
Rodrigo Santibáñez

Behavioral Neurologist

Neurology

Pontificia Universidad Católica de Chile

Santiago, Chile

2
Claudia Duran-Aniotz

Profesor Asociado

Escuela de Psicología

Universidad Adolfo Ibánez

Santiago, Chile

2
Agustin Ibanez

Profesor Titular

Psicologia

Universidad Adolfo Ibánez

Santiago, Chile

1
Andrea Slachevsky

Associate Professor

ICBM

UNIVERSIDAD DE CHILE

Chile, Chile

1
Josefina Cruzat

Profesor Asistente

Psicología

Universidad Adolfo Ibánez

Santiago, Chile

1
Christian Gonzalez

Full Professor

Biology

Universidad de Chile

Santiago, Chile

1
Gorka Navarrete

Adjunct Professor

Psychology

Universidad Adolfo Ibánez

Santiago, Chile